...
首页> 外文期刊>Annals of anatomy =: Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft >Differential cellular expression of FXYD1 (phospholemman) and FXYD2 (gamma subunit of Na, K-ATPase) in normal human tissues: a study using high density human tissue microarrays.
【24h】

Differential cellular expression of FXYD1 (phospholemman) and FXYD2 (gamma subunit of Na, K-ATPase) in normal human tissues: a study using high density human tissue microarrays.

机译:正常人体组织中FXYD1(磷脂酶)和FXYD2(Na的γ亚基,K-ATPase)的细胞差异表达:使用高密度人体组织微阵列的研究。

获取原文
获取原文并翻译 | 示例
           

摘要

FXYD proteins have been proposed to function as regulators of Na, K-ATPase function by lowering affinities of the system for potassium and sodium. However, their distribution in normal human tissues has not been studied. We have therefore used immunohistochemistry and semi-quantitative histomorphometric analysis to determine the relative expression at the protein level and distribution of FXYD1 (phospholemman) and FXYD2 (gamma subunit of Na, K-ATPase) in human Tissue MicroArrays (TMAs). Expression of FXYD1 was abundant in heart, kidney, placenta, skeletal muscle, gastric and anal mucosa, small intestine and colon. Lower FXYD1 expression was detected in uterine, intestinal and bladder smooth muscle, choroid plexus, liver, gallbladder, spleen, breast, prostate and epididymis. The tissue distribution of FXYD2 was less extensive compared to that of FXYD1. There was an abundant expression in kidney and choroid plexus and moderate expression in placenta, amniotic membranes, breast epithelium, salivary glands, pancreas and uterine endometrium. Weaker FXYD2 expression was detected in the adrenal medulla, liver, gallbladder, bladder and pancreas. The common denominator in the distribution of FXYD1 and FXYD2 was expression in highly active transport epithelia of the kidney, choroid plexus, placenta and salivary glands. This study reveals, in human tissues, the specific expression of FXYD proteins, which may associate with Na, K-ATPase in selected cell types and modulate its catalytic properties.
机译:已经提出通过降低系统对钾和钠的亲和力,FXYD蛋白起Na,K-ATPase功能的调节作用。然而,尚未研究它们在正常人组织中的分布。因此,我们使用了免疫组织化学和半定量组织形态计量学分析来确定人类组织微阵列(TMA)中蛋白质水平上的相对表达以及FXYD1(磷脂酶)和FXYD2(Na,K-ATPase的γ亚基)的分布。 FXYD1在心脏,肾脏,胎盘,骨骼肌,胃和肛门粘膜,小肠和结肠中表达丰富。在子宫,肠和膀胱平滑肌,脉络丛,肝脏,胆囊,脾脏,乳房,前列腺和附睾中检测到较低的FXYD1表达。与FXYD1相比,FXYD2的组织分布范围较小。在肾脏和脉络丛中有大量表达,在胎盘,羊膜,乳腺上皮,唾液腺,胰腺和子宫内膜中有中等表达。在肾上腺髓质,肝脏,胆囊,膀胱和胰腺中检测到较弱的FXYD2表达。 FXYD1和FXYD2分布的共同点是在肾脏,脉络丛,胎盘和唾液腺的高活性转运上皮中表达。这项研究揭示了在人体组织中FXYD蛋白的特异性表达,该蛋白可能与某些细胞类型中的Na,K-ATPase相关,并调节其催化特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号